L-Serine
L-Serine
L-Serine is a conditionally non-essential amino acid that plays a central role in neurological function, phospholipid synthesis, and one-carbon metabolism. It is used therapeutically for conditions involving neurodegeneration, particularly ALS and hereditary sensory and autonomic neuropathy type 1 (HSAN1), and is also explored for cognitive support and glycine synthesis. Unlike most amino acids, L-serine has a dedicated transport system across the blood-brain barrier and serves as the primary precursor to several neuroactive compounds.
Mechanism of Action
L-Serine is converted to glycine and D-serine via serine hydroxymethyltransferase and serine racemase, respectively; D-serine acts as an obligatory co-agonist at NMDA receptors, directly modulating glutamatergic neurotransmission and synaptic plasticity. It is also an essential precursor for phosphatidylserine and sphingolipid biosynthesis, and competes with the neurotoxic amino acid L-BMAA for incorporation into proteins, which is particularly relevant in the context of ALS-linked neurodegeneration. In one-carbon metabolism, serine donates a methyl group via the folate cycle, supporting methylation reactions critical for DNA synthesis and epigenetic regulation.
Evidence by Health Goal(9 goals)
Dosing Protocols
With or without food; splitting doses improves tolerability and sustained plasma levels
Doses used in ALS and HSAN1 clinical trials typically range from 15-30g/day. Cognitive and general supplementation purposes may use lower doses of 1-5g/day. Start at lower doses and titrate up to assess GI tolerance.
Safety & Side Effects
L-Serine has a well-established safety profile in clinical trials at doses up to 30g/day, with the primary dose-limiting factor being gastrointestinal tolerability rather than systemic toxicity. It is not a controlled substance and is available without prescription, though individuals with kidney disease, seizure disorders, or those on NMDA-modulating medications should consult a physician before use.
Possible Side Effects
- !Gastrointestinal discomfort including nausea and loose stools at high doses (>10g/day)
- !Bloating and flatulence, particularly when dose-escalating rapidly
- !Sedation or mild drowsiness, likely mediated via glycine and D-serine production
- !Headache reported in a subset of users during initial supplementation
- !Hypoglycemic-like symptoms at very high doses due to effects on glucose metabolism
- !Theoretical NMDA receptor over-stimulation at extremely high doses, though not well-documented clinically
Interactions
- -May potentiate NMDA receptor activity when combined with other NMDA co-agonists such as glycine or D-serine supplements - monitor for over-stimulation
- -Could theoretically enhance the effects of memantine (NMDA antagonist) by increasing co-agonist tone - clinical significance unclear
- -May reduce incorporation of neurotoxic amino acid L-BMAA into proteins, suggesting a potential protective interaction relevant to cyanobacterial toxin exposure
- -High-dose supplementation may affect folate-cycle dynamics and interact with methotrexate or other antifolate drugs by altering methyl-group availability
- -Combined use with high-dose glycine supplements may produce additive sedative or CNS-depressant effects
Cost & Where to Buy
Cost varies significantly based on dose; lower doses for cognitive support (1-5g/day) are inexpensive, while therapeutic doses for ALS (15-30g/day) require bulk powder purchases. Bulk pharmaceutical-grade L-serine powder offers the best value for high-dose protocols.
Search on Amazon